Skip to main content
. Author manuscript; available in PMC: 2013 Feb 6.
Published in final edited form as: AIDS Educ Prev. 2009 Jun;21(3 Suppl):65–80. doi: 10.1521/aeap.2009.21.3_supp.65

TABLE 3.

Predictors of 6-Month Change in Self-Efficacy (N = 412)

Regression Coefficient Value LCL UCL p
Intercepta 0.49 0.31 0.66 < .001
Hispanic American versus European American 0.35 −0.01 0.71 .058
African American versus European American 0.35 0.01 0.69 .045
Other versus European American 0.02 −0.38 0.42 .933
Baseline self-efficacy −0.26 −0.40 −0.13 .001
Baseline decisional balance 0.05 −0.08 0.19 .428
NRT-related contacts 0.19 0.10 0.28 < .001

Note. LCL = 95% lower confidence limit; UCL = 95% upper confidence limit; NRT = nicotine replacement therapy.

a

Intercept gives the baseline odds for European Americans.